Up & At 'em Therapy Staffing Llc | |
1012 Main St, Alamosa, CO 81101-2445 | |
(719) 480-3438 | |
Not Available |
Full Name | Up & At 'em Therapy Staffing Llc |
---|---|
Type | Facility |
Speciality | Clinic/center - Rehabilitation, Comprehensive Outpatient Rehabilitation Facility (corf) |
Location | 1012 Main St, Alamosa, Colorado |
Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1174864359 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Up & At 'em Therapy Staffing Llc Po Box 1294, Alamosa, CO 81101-1294 Ph: (719) 480-3438 | Up & At 'em Therapy Staffing Llc 1012 Main St, Alamosa, CO 81101-2445 Ph: (719) 480-3438 |
News Archive
According to Dutch researchers, duct tape is ineffective in curing warts, a view which contradicts a common theory on how to get rid of the ugly skin blemishes.
In this post in RH Reality Check, Jodi Jacobson, editor-in-chief of the blog, responds to an article published in the New York Times on Tuesday regarding a study suggesting that "HIV-negative women using injectable contraception might face a two-fold risk of acquiring HIV from their infected partners, and that HIV-positive women using injectable contraceptives may be twice as likely to pass the virus on to their uninfected partners."
Results of a study by The Wistar Institute have described a correlation between a key melanoma signaling pathway and a novel class of drugs being tested in the clinic as adjuvant therapy for advanced melanoma, providing useful information for a more effective use of this type of treatment.
ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc, with Pfizer Inc. and Shionogi Limited as shareholders, is pleased to announce that eligible people living with Human Immunodeficiency Virus (HIV) in England and Wales will soon have routine access to Vocabria (cabotegravir long-acting injection) developed by ViiV Healthcare in combination with Rekambys (rilpivirine long-acting injection), developed by Janssen Sciences Ireland UC (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson.
Building on prior research that examined the use of an arthritis medication to treat vitiligo, a team of Yale dermatologists has successfully applied a novel combination therapy - the medication and light - to restore skin color in patients.
› Verified 7 days ago